IMMUTRIN LTD

Active Cambridge

Research and experimental development on biotechnology

8 employees website.com
Professional services Other Professional services Research and experimental development on biotechnology
I

IMMUTRIN LTD

Research and experimental development on biotechnology

Founded 20 Sept 2019 Active Cambridge, United Kingdom 8 employees website.com
Professional services Other Professional services Research and experimental development on biotechnology
Accounts Submitted 30 Mar 2026 Next due 31 May 2027 13 months remaining
Confirmation
Net assets £601K £144K 2025 year on year
Total assets £782K £221K 2025 year on year
Total Liabilities £181K £77K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Cambridge Innovation Capital 22 Station Road Cambridge CB1 2JD United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for IMMUTRIN LTD (12217886), an active professional services company based in Cambridge, United Kingdom. Incorporated 20 Sept 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2020–2025)

Cash in Bank

£550.93k

Decreased by £179.50k (-25%)

Net Assets

£600.77k

Decreased by £144.18k (-19%)

Total Liabilities

£180.78k

Decreased by £77.17k (-30%)

Turnover

N/A

Employees

8

Increased by 4 (+100%)

Debt Ratio

23%

Decreased by 3 (-12%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Dec 2019Seed
Investor 2Dec 2019Seed

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 224,820 Shares £7.50m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
10 Feb 202678,124£3.75m£48
25 Sept 202431,250£1.25m£40
4 Apr 202335,223£950k£26.97
17 Feb 20239,269£250k£26.97
15 Feb 202325,954£700k£26.97

Officers

Officers

3 active
Status
Michael Leith AnsteyDirectorBritishUnited Kingdom453 Dec 2019Active
Mihriban TunaDirectorBritishUnited Kingdom526 Feb 2024Active
Sinclair-wilson, Alexander Jack KellowDirectorBritishUnited Kingdom392 Feb 2026Active

Shareholders

Shareholders (12)

Professor Mark Brian Pepys
12.9%
30,600
Molecular Advances Pty Ltd
12.5%
29,700

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased
Notified 31 Mar 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Professor Mark Brian Pepys

Ceased 31 Mar 2022

Ceased

Daniel Christ

Ceased 3 Dec 2019

Ceased

Gregory Paul Winter

Ceased 3 Dec 2019

Ceased

Group Structure

Group Structure

IMMUTRIN LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Apr 2026ResolutionResolutions
30 Mar 2026AccountsAnnual accounts made up to 2026-08-31
16 Mar 2026CapitalAllotment of shares (GBP 314.82) on 2026-02-10
28 Feb 2026IncorporationMemorandum Articles
20 Feb 2026ResolutionResolutions
13 Apr 2026 Resolution

Resolutions

30 Mar 2026 Accounts

Annual accounts made up to 2026-08-31

16 Mar 2026 Capital

Allotment of shares (GBP 314.82) on 2026-02-10

28 Feb 2026 Incorporation

Memorandum Articles

20 Feb 2026 Resolution

Resolutions

Recent Activity

Latest Activity

Resolutions

1 weeks ago on 13 Apr 2026

Annual accounts made up to 2026-08-31

3 weeks ago on 30 Mar 2026

Allotment of shares (GBP 314.82) on 2026-02-10

1 months ago on 16 Mar 2026

Memorandum Articles

1 months ago on 28 Feb 2026

Resolutions

2 months ago on 20 Feb 2026